デフォルト表紙
市場調査レポート
商品コード
1449396

痔瘻治療市場、シェア、市場規模、動向、産業分析レポート:薬剤タイプ別、治療タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024-2032年

Anal Fistula Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Anticholinergic, Proton-Pump Inhibitors, H2 Blockers, Antidiarrheals); By Treatment Type; By Application, By End Use, By Region, & Segment Forecasts, 2024-2032

出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
痔瘻治療市場、シェア、市場規模、動向、産業分析レポート:薬剤タイプ別、治療タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024-2032年
出版日: 2024年02月24日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の痔瘻治療市場規模は2032年までに413億4,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

痔瘻治療市場は、この疾患の世界の有病率の上昇に後押しされて成長を経験しています。炎症性腸疾患は主な原因であり、特定できる誘因のない消化管(GI)の持続的な慢性炎症につながります。腸瘻治療分野の収益拡大は、製品開発の進歩、医薬品の承認、予測期間を通じて生物学的製剤やバイオシミラー医薬品への嗜好の高まりといった要因によって予測されます。

単一細胞RNAシーケンスに代表される技術の進歩は、医療従事者が肛門瘻治療を管理する上で役立っています。クローン病や潰瘍性大腸炎と診断された患者から得られた腸管検体には、単一細胞RNAシーケンスやマスサイトメトリーなどの高次元技術が適用されています。シングルセルRNAシーケンス解析の利用は、革新的な治療戦略の探求、個々の薬剤のカスタマイズ、疾患の予防など、疾患の分子基盤を理解する上でさまざまな利点をもたらします。

痔瘻治療市場の有病率上昇には、遺伝的素因、環境的誘因、クローン病としばしば関連する免疫系の調節異常など、複数の要因が寄与しています。潰瘍性大腸炎やクローン病と診断された患者のかなりの割合が、家族性の病歴を示します。例えば、Hopkins Medicineの調査によると、クローン病患者の約10~15%にクローン病に罹患した親族がいます。同様に、潰瘍性大腸炎と診断された患者の約5~7%に家族歴があります。

ヘルスケアコストを軽減するために業界の主要企業が実施する償還戦略により、効果的な治療オプションに関する患者の好意的な認識が促進されると予想されます。腸瘻治療への投資の増加も、特に医師が中等度から重度の腸瘻症を管理するためにこれらの薬剤を処方するのが一般的であることから、大きな投資収益率(ROI)をもたらすと予測されます。さらに、抗癒着分子、特にインテグリン拮抗薬の開発は、肛門瘻に対処するための有望な道を示しています。これらの分子は、癒着形成に関与する分子メカニズムを標的とし、瘻孔の再発を減少させ、患者の転帰を改善する可能性があります。

痔瘻治療市場レポートハイライト

2023年では、肛門瘻への対応として患者に推奨され、好まれるアプローチとして登場した介入、特に瘻孔手術により、外科分野が最大の市場シェアを占めました。

病院セグメントは、手術ユニットや診断能力を含む高度な医療インフラを備えた専門的な診療科や施設により、予測期間中に最も速いCAGRを記録すると予想されます。

北米は、設備の整った病院、診療所、専門医療施設を備えた高度なヘルスケア・インフラにより、2023年に最大の市場シェアを占めました。最先端の診断・治療リソースを利用できることは、効果的かつ包括的な痔瘻管理に寄与します。

アジア太平洋地域は、腸疾患を患う膨大な人口の存在により、予測期間中に最も速いCAGRを記録すると予想されます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の痔瘻治療市場に関する洞察

  • 痔瘻の治療- 業界スナップショット
  • 痔瘻治療市場力学
    • 促進要因と機会
      • 腸疾患の発生率の増加
      • 治療技術の進歩
    • 抑制要因と課題
      • 高額な治療費
  • PESTLE分析
  • 痔瘻治療業界の動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の痔瘻治療市場、薬剤の種類別

  • 主な調査結果
  • イントロダクション
  • 抗コリン作用
  • プロトンポンプ阻害剤
  • H2ブロッカー
  • 下痢止め

第6章 世界の痔瘻治療市場、用途別

  • 主な調査結果
  • イントロダクション
  • 括約筋間瘻
  • 経括約筋瘻
  • 括約筋上瘻
  • その他

第7章 世界の痔瘻治療市場、エンドユース別

  • 主な調査結果
  • イントロダクション
  • 病院
  • 外来手術センター
  • その他

第8章 世界の痔瘻治療市場、治療タイプ別

  • 主な調査結果
  • イントロダクション
  • 外科的
  • 非外科的

第9章 世界の痔瘻治療市場、地域別

  • 主な調査結果
  • イントロダクション
    • 痔瘻治療市場評価、地域別、2019-2032年
  • 痔瘻治療市場-北米
    • 北米:痔瘻治療市場、医薬品タイプ別、2019-2032年
    • 北米:痔瘻治療市場、治療タイプ別、2019~2032年
    • 北米:痔瘻治療市場、用途別、2019-2032年
    • 北米:痔瘻治療市場、エンドユース別、2019-2032年
    • 痔瘻治療市場-米国
    • 痔瘻治療市場- カナダ
  • 痔瘻治療市場- 欧州
    • 欧州:痔瘻治療市場、薬剤タイプ別、2019~2032年
    • 欧州:痔瘻治療市場、治療タイプ別、2019~2032年
    • 欧州:痔瘻治療市場、用途別、2019~2032年
    • 欧州:痔瘻治療市場、エンドユース別、2019~2032年
    • 痔瘻治療市場- 英国
    • 痔瘻治療市場- フランス
    • 痔瘻治療市場- ドイツ
    • 痔瘻治療市場- イタリア
    • 痔瘻治療市場- スペイン
    • 痔瘻治療市場- オランダ
    • 痔瘻治療市場- ロシア
  • 痔瘻治療市場- アジア太平洋地域
    • アジア太平洋地域:痔瘻治療市場、薬剤タイプ別、2019~2032年
    • アジア太平洋地域:痔瘻治療市場、治療タイプ別、2019~2032年
    • アジア太平洋地域:痔瘻治療市場、用途別、2019~2032年
    • アジア太平洋地域:痔瘻治療市場、エンドユース別、2019~2032年
    • 痔瘻治療市場- 中国
    • 痔瘻治療市場- インド
    • 痔瘻治療市場- 日本
    • 痔瘻治療市場- マレーシア
    • 痔瘻治療市場- インドネシア
    • 痔瘻治療市場- 韓国
  • 痔瘻治療市場-中東およびアフリカ
    • 中東およびアフリカ:痔瘻治療市場、薬剤タイプ別、2019~2032年
    • 中東およびアフリカ:痔瘻治療市場、治療タイプ別、2019~2032年
    • 中東およびアフリカ:痔瘻治療市場、用途別、2019~2032年
    • 中東およびアフリカ:痔瘻治療市場、エンドユース別、2019~2032年
    • 痔瘻治療市場- サウジアラビア
    • 痔瘻治療市場- 南アフリカ
    • 痔瘻治療市場- イスラエル
    • 痔瘻治療市場- アラブ首長国連邦
  • 痔瘻治療市場-ラテンアメリカ
    • ラテンアメリカ:痔瘻治療市場、薬剤タイプ別、2019-2032年
    • ラテンアメリカ:痔瘻治療市場、治療タイプ別、2019~2032年
    • ラテンアメリカ:痔瘻治療市場、用途別、2019-2032年
    • ラテンアメリカ:痔瘻治療市場、エンドユース別、2019-2032年
    • 痔瘻治療市場- メキシコ
    • 痔瘻治療市場- ブラジル
    • 痔瘻治療市場- アルゼンチン

第10章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第11章 企業プロファイル

  • Angiplast Pvt. Ltd.
  • Avante Health Solutions
  • Biolitec AG
  • Cliniva Healthcare
  • Cook Medical
  • Gulmaher Surgico
  • Integra LifeSciences
  • KARL STORZ
  • Medtronic plc
  • Novo Surgical Inc.
  • Signum Surgical
  • Sklar Surgical Instruments
図表

List of Tables

  • Table 1 Global Anal Fistula Treatment Market, by Drug Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Anal Fistula Treatment Market, by Application, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Anal Fistula Treatment Market, by End-use, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Anal Fistula Treatment Market, by Treatment Type, by Region, 2019-2032 (USD Billion)
  • Table 5 Anal Fistula Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 7 North America: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 8 North America: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 9 North America: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 11 U.S.: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 12 U.S.: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 13 U.S.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 14 Canada: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 15 Canada: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Canada: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 17 Canada: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 18 Europe: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 19 Europe: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 20 Europe: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 21 Europe: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 22 Germany: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 23 Germany: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 24 Germany: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 25 Germany: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 26 France: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 27 France: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 28 France: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 29 France: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 30 UK: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 31 UK: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 32 UK: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 33 UK: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 34 Italy: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 35 Italy: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 36 Italy: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 37 Italy: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 42 Spain: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 43 Spain: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 44 Spain: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 45 Spain: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 46 Russia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 47 Russia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 48 Russia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 49 Russia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 54 China: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 55 China: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 56 China: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 57 China: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 58 Japan: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 59 Japan: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 60 Japan: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 61 Japan: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 62 India: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 63 India: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 64 India: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 65 India: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 74 South Korea: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 75 South Korea: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 76 South Korea: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 77 South Korea: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 78 Latin America: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 79 Latin America: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 80 Latin America: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 81 Latin America: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 83 Brazil: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 84 Brazil: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 85 Brazil: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 86 Mexico: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 87 Mexico: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 88 Mexico: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 89 Mexico: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 90 Argentina: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 91 Argentina: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 92 Argentina: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 93 Argentina: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 98 UAE: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 99 UAE: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 100 UAE: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 101 UAE: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 106 South Africa: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 107 South Africa: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 108 South Africa: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 109 South Africa: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 110 Israel: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 111 Israel: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • Table 112 Israel: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • Table 113 Israel: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Anal Fistula Treatment Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Treatment Type
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Drug Type
  • Figure 7. Global Anal Fistula Treatment Market, by Drug Type, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Treatment Type
  • Figure 9. Global Anal Fistula Treatment Market, by Treatment Type, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Anal Fistula Treatment Market, by Application, 2021 & 2030 (USD Billion)
  • Figure 12. Market by End-use
  • Figure 13. Global Anal Fistula Treatment Market, by End-use, 2021 & 2030 (USD Billion)
目次
Product Code: PM4582

The global anal fistula treatment market size is expected to reach USD 41.34 billion by 2032, according to a new study by Polaris Market Research. The report "Anal Fistula Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Anticholinergic, Proton-Pump Inhibitors, H2 Blockers, Antidiarrheals); By Treatment Type; By Application, By End Use, By Region, And Segment Forecasts, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The anal fistula treatment market is experiencing growth propelled by the global increase in the prevalence of this condition. Inflammatory bowel diseases are a primary cause, leading to persistent chronic inflammation of the gastrointestinal (GI) tract without identifiable triggers. Revenue expansion in the intestinal fistula treatment sector is anticipated due to factors like advancements in product development, drug approvals, and a growing preference for biologic and biosimilar medications throughout the forecast period.

Advancements in technology, exemplified by single-cell RNA sequencing, are aiding healthcare practitioners in managing anal fistula treatment. High-dimensional techniques like single-cell RNA sequencing and mass cytometry have been applied to intestinal specimens obtained from individuals diagnosed with Crohn's disease or ulcerative colitis. The utilization of single-cell RNA sequencing analysis offers various advantages in comprehending the molecular underpinnings of the disease, including the exploration of innovative therapeutic strategies, customization of individual medications, and disease prevention.

Multiple factors contribute to the escalating prevalence of the anal fistula treatment market, including genetic predisposition, environmental triggers, and immune system dysregulation, often associated with the Crohn's Disease. A significant proportion of patients diagnosed with ulcerative colitis or Crohn's disease exhibit a familial history of the condition. For instance, research conducted by Hopkins Medicine indicates that approximately 10 to 15% of individuals with Crohn's disease have relatives affected by the disorder. Similarly, around 5 to 7% of patients diagnosed with ulcerative colitis have a familial history of the condition.

Reimbursement strategies implemented by key industry players to mitigate healthcare costs are expected to foster favorable patient perceptions regarding effective treatment options. Increased investments in intestinal fistula treatment are also projected to yield significant returns on investment (ROI), particularly as physicians commonly prescribe these medications for managing moderate to severe intestinal fistula cases. Furthermore, the development of anti-adhesion molecules, particularly integrin antagonists, presents a promising avenue for addressing anal fistula. These molecules target the molecular mechanisms involved in adhesion formation, potentially reducing the recurrence of fistulas and improving patient outcomes.

Anal Fistula Treatment Market Report Highlights

In 2023, the surgical segment accounted for the largest market share due to interventions, particularly fistula surgery, that emerged as the recommended and preferred approach for addressing anal fistulas among patients.

The hospital segment is expected to witness the fastest CAGR during the forecast period due to specialized departments and facilities equipped with advanced medical infrastructure, including surgical units and diagnostic capabilities.

North America dominated the largest market share in 2023, due to advanced healthcare infrastructure with well-equipped hospitals, clinics, and specialized healthcare facilities. The availability of state-of-the-art diagnostic and treatment resources contributes to effective and comprehensive anal fistula management.

Asia Pacific region is expected to witness the fastest CAGR during the forecast period on account of the presence of a huge population suffering from intestinal disorders.

The global players include Avante Health, Biolitec, Cliniva Healthcare, Cook Medical, Gulmaher Surgico, KARL STORZ, Novo Surgical, and more.

Polaris Market Research has segmented the anal fistula treatment market report based on drug type, treatment type, application, end use, and region:

Anal Fistula Treatment, Durg Type Outlook (Revenue - USD Billion, 2019- 2032)

  • Anticholinergic
  • Proton-Pump Inhibitors
  • H2 Blockers
  • Antidiarrheals

Anal Fistula Treatment, Treatment Type Outlook (Revenue - USD Billion, 2019- 2032)

  • Surgical
  • Non-Surgical

Anal Fistula Treatment, Application Outlook (Revenue - USD Billion, 2019- 2032)

  • Intersphincteric Fistula
  • Transsphincteric Fistula
  • Suprasphincteric Fistula
  • Others

Anal Fistula Treatment, End Use Outlook (Revenue - USD Billion, 2019- 2032)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Anal Fistula Treatment, Regional Outlook (Revenue - USD Billion, 2019- 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of LA
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1.Introduction

  • 1.1.Report Description
    • 1.1.1.Objectives of the Study
    • 1.1.2.Market Scope
    • 1.1.3.Assumptions
  • 1.2.Stakeholders

2.Executive Summary

  • 2.1.Market Highlights

3.Research Methodology

  • 3.1.Overview
    • 3.1.1.Data Mining
  • 3.2.Data Sources
    • 3.2.1.Primary Sources
    • 3.2.2.Secondary Sources

4.Global Anal Fistula Treatment Market Insights

  • 4.1.Anal Fistula Treatment - Industry Snapshot
  • 4.2.Anal Fistula Treatment Market Dynamics
    • 4.2.1.Drivers and Opportunities
      • 4.2.1.1.Rising incidence of bowel diseases
      • 4.2.1.2.Advancements in Treatment Technologies
    • 4.2.2.Restraints and Challenges
      • 4.2.2.1.High cost of treatment
  • 4.3.Porter's Five Forces Analysis
    • 4.3.1.Bargaining Power of Suppliers (Moderate)
    • 4.3.2.Threats of New Entrants: (Low)
    • 4.3.3.Bargaining Power of Buyers (Moderate)
    • 4.3.4.Threat of Substitute (Moderate)
    • 4.3.5.Rivalry among existing firms (High)
  • 4.4.PESTLE Analysis
  • 4.5.Anal Fistula Treatment Industry Trends
  • 4.6.Value Chain Analysis
  • 4.7.COVID-19 Impact Analysis

5.Global Anal Fistula Treatment Market, by Drug Type

  • 5.1.Key Findings
  • 5.2.Introduction
    • 5.2.1.Global Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • 5.3.Anticholinergic
    • 5.3.1.Global Anal Fistula Treatment Market, by Anticholinergic, by Region, 2019-2032 (USD Billion)
  • 5.4.Proton-Pump Inhibitors
    • 5.4.1.Global Anal Fistula Treatment Market, by Proton-Pump Inhibitors, by Region, 2019-2032 (USD Billion)
  • 5.5.H2 Blockers
    • 5.5.1.Global Anal Fistula Treatment Market, by H2 Blockers, by Region, 2019-2032 (USD Billion)
  • 5.6.Antidiarrheals
    • 5.6.1.Global Anal Fistula Treatment Market, by Antidiarrheals, by Region, 2019-2032 (USD Billion)

6.Global Anal Fistula Treatment Market, by Application

  • 6.1.Key Findings
  • 6.2.Introduction
    • 6.2.1.Global Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • 6.3.Intersphincteric Fistula
    • 6.3.1.Global Anal Fistula Treatment Market, by Intersphincteric Fistula, by Region, 2019-2032 (USD Billion)
  • 6.4.Transsphincteric Fistula
    • 6.4.1.Global Anal Fistula Treatment Market, by Transsphincteric Fistula, by Region, 2019-2032 (USD Billion)
  • 6.5.Suprasphincteric Fistula
    • 6.5.1.Global Anal Fistula Treatment Market, by Suprasphincteric Fistula, by Region, 2019-2032 (USD Billion)
  • 6.6.Others
    • 6.6.1.Global Anal Fistula Treatment Market, by Others, by Region, 2019-2032 (USD Billion)

7.Global Anal Fistula Treatment Market, by End-use

  • 7.1.Key Findings
  • 7.2.Introduction
    • 7.2.1.Global Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 7.3.Hospitals
    • 7.3.1.Global Anal Fistula Treatment Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 7.4.Ambulatory Surgical Centers
    • 7.4.1.Global Anal Fistula Treatment Market, by Ambulatory Surgical Centers, by Region, 2019-2032 (USD Billion)
  • 7.5.Others
    • 7.5.1.Global Anal Fistula Treatment Market, by Others, by Region, 2019-2032 (USD Billion)

8.Global Anal Fistula Treatment Market, by Treatment Type

  • 8.1.Key Findings
  • 8.2.Introduction
    • 8.2.1.Global Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • 8.3.Surgical
    • 8.3.1.Global Anal Fistula Treatment Market, by Surgical, by Region, 2019-2032 (USD Billion)
  • 8.4.Non-Surgical
    • 8.4.1.Global Anal Fistula Treatment Market, by Non-Surgical, by Region, 2019-2032 (USD Billion)

9.Global Anal Fistula Treatment Market, by Geography

  • 9.1.Key findings
  • 9.2.Introduction
    • 9.2.1.Anal Fistula Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3.Anal Fistula Treatment Market - North America
    • 9.3.1.North America: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.3.2.North America: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.3.3.North America: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.3.4.North America: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.3.5.Anal Fistula Treatment Market - U.S.
      • 9.3.5.1.U.S.: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.3.5.2.U.S.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.3.5.3.U.S.: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.3.5.4.U.S.: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.3.6.Anal Fistula Treatment Market - Canada
      • 9.3.6.1.Canada: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.3.6.2.Canada: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.3.6.3.Canada: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.3.6.4.Canada: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.4.Anal Fistula Treatment Market - Europe
    • 9.4.1.Europe: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.4.2.Europe: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.4.3.Europe: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.4.4.Europe: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.5.Anal Fistula Treatment Market - UK
      • 9.4.5.1.UK: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.5.2.UK: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.5.3.UK: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.5.4.UK: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.6.Anal Fistula Treatment Market - France
      • 9.4.6.1.France: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.6.2.France: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.6.3.France: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.6.4.France: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.7.Anal Fistula Treatment Market - Germany
      • 9.4.7.1.Germany: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.7.2.Germany: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.7.3.Germany: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.7.4.Germany: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.8.Anal Fistula Treatment Market - Italy
      • 9.4.8.1.Italy: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.8.2.Italy: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.8.3.Italy: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.8.4.Italy: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.9.Anal Fistula Treatment Market - Spain
      • 9.4.9.1.Spain: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.9.2.Spain: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.9.3.Spain: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.9.4.Spain: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.10.Anal Fistula Treatment Market - Netherlands
      • 9.4.10.1.Netherlands: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.10.2.Netherlands: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.10.3.Netherlands: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.10.4.Netherlands: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.11.Anal Fistula Treatment Market - Russia
      • 9.4.11.1.Russia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.11.2.Russia.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.11.3.Russia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.11.4.Russia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.5.Anal Fistula Treatment Market - Asia Pacific
    • 9.5.1.Asia Pacific: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.5.2.Asia Pacific: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.5.3.Asia Pacific: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.5.4.Asia Pacific: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.5.Anal Fistula Treatment Market - China
      • 9.5.5.1.China: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.5.2.China.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.5.3.China: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.5.4.China: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.6.Anal Fistula Treatment Market - India
      • 9.5.6.1.India: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.6.2.India.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.6.3.India: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.6.4.India: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.7.Anal Fistula Treatment Market - Japan
      • 9.5.7.1.Japan: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.7.2.Japan.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.7.3.Japan: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.7.4.Japan: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.8.Anal Fistula Treatment Market - Malaysia
      • 9.5.8.1.Malaysia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.8.2.Malaysia.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.8.3.Malaysia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.8.4.Malaysia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.9.Anal Fistula Treatment Market - Indonesia
      • 9.5.9.1.Indonesia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.9.2.Indonesia.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.9.3.Indonesia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.9.4.Indonesia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.10.Anal Fistula Treatment Market - South Korea
      • 9.5.10.1.South Korea: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.10.2.South Korea.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.10.3.South Korea: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.10.4.South Korea: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.6.Anal Fistula Treatment Market - Middle East & Africa
    • 9.6.1.Middle East & Africa: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.6.2.Middle East & Africa: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.6.3.Middle East & Africa: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.6.4.Middle East & Africa: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.5.Anal Fistula Treatment Market - Saudi Arabia
      • 9.6.5.1.Saudi Arabia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.5.2.Saudi Arabia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.5.3.Saudi Arabia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.5.4.Saudi Arabia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.6.Anal Fistula Treatment Market - South Africa
      • 9.6.6.1.South Africa: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.6.2.South Africa: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.6.3.South Africa: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.6.4.South Africa: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.7.Anal Fistula Treatment Market - Israel
      • 9.6.7.1.Israel: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.7.2.Israel: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.7.3.Israel: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.7.4.Israel: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.8.Anal Fistula Treatment Market - UAE
      • 9.6.8.1.UAE: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.8.2.UAE: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.8.3.UAE: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.8.4.UAE: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.7.Anal Fistula Treatment Market - Latin America
    • 9.7.1.Latin America: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.7.2.Latin America: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.7.3.Latin America: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.7.4.Latin America: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.7.5.Anal Fistula Treatment Market - Mexico
      • 9.7.5.1.Mexico: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.7.5.2.Mexico: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.7.5.3.Mexico: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.7.5.4.Mexico: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.7.6.Anal Fistula Treatment Market - Brazil
      • 9.7.6.1.Brazil: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.7.6.2.Brazil: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.7.6.3.Brazil: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.7.6.4.Brazil: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.7.7.Anal Fistula Treatment Market - Argentina
      • 9.7.7.1.Argentina: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.7.7.2.Argentina: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.7.7.3.Argentina: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.7.7.4.Argentina: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)

10.Competitive Landscape

  • 10.1.Expansion and Acquisition Analysis
    • 10.1.1.Expansion
    • 10.1.2.Acquisitions
  • 10.2.Partnerships/Collaborations/Agreements/Exhibitions

11.Company Profiles

  • 11.1.Angiplast Pvt. Ltd.
    • 11.1.1.Company Overview
    • 11.1.2.Financial Performance
    • 11.1.3.Product Benchmarking
    • 11.1.4.Recent Development
  • 11.2.Avante Health Solutions
    • 11.2.1.Company Overview
    • 11.2.2.Financial Performance
    • 11.2.3.Product Benchmarking
    • 11.2.4.Recent Development
  • 11.3.Biolitec AG
    • 11.3.1.Company Overview
    • 11.3.2.Financial Performance
    • 11.3.3.Product Benchmarking
    • 11.3.4.Recent Development
  • 11.4.Cliniva Healthcare
    • 11.4.1.Company Overview
    • 11.4.2.Financial Performance
    • 11.4.3.Product Benchmarking
    • 11.4.4.Recent Development
  • 11.5.Cook Medical
    • 11.5.1.Company Overview
    • 11.5.2.Financial Performance
    • 11.5.3.Product Benchmarking
    • 11.5.4.Recent Development
  • 11.6.Gulmaher Surgico
    • 11.6.1.Company Overview
    • 11.6.2.Financial Performance
    • 11.6.3.Product Benchmarking
    • 11.6.4.Recent Development
  • 11.7.Integra LifeSciences
    • 11.7.1.Company Overview
    • 11.7.2.Financial Performance
    • 11.7.3.Product Benchmarking
    • 11.7.4.Recent Development
  • 11.8.KARL STORZ
    • 11.8.1.Company Overview
    • 11.8.2.Financial Performance
    • 11.8.3.Product Benchmarking
    • 11.8.4.Recent Development
  • 11.9.Medtronic plc
    • 11.9.1.Company Overview
    • 11.9.2.Financial Performance
    • 11.9.3.Product Benchmarking
    • 11.9.4.Recent Development
  • 11.10.Novo Surgical Inc.
    • 11.10.1.Company Overview
    • 11.10.2.Financial Performance
    • 11.10.3.Product Benchmarking
    • 11.10.4.Recent Development
  • 11.11.Signum Surgical
    • 11.11.1.Company Overview
    • 11.11.2.Financial Performance
    • 11.11.3.Product Benchmarking
    • 11.11.4.Recent Development
  • 11.12.Sklar Surgical Instruments
    • 11.12.1.Company Overview
    • 11.12.2.Financial Performance
    • 11.12.3.Product Benchmarking
    • 11.12.4.Recent Development